The immunity and protective effects of antigen 85A and heat-shock protein X against progressive tuberculosis.

[1]  B. Kreiswirth,et al.  Mycobacterium bovis BCG Immunization Induces Protective Immunity against Nine Different Mycobacterium tuberculosis Strains in Mice , 2008, Infection and Immunity.

[2]  H. Dockrell,et al.  Persistence of the immune response induced by BCG vaccination , 2008, BMC infectious diseases.

[3]  S-N Cho,et al.  Protection of Mice against Mycobacterium tuberculosis Infection by Immunization with Aqueous Fraction of Triton X‐100‐soluble Cell Wall Proteins , 2007, Scandinavian journal of immunology.

[4]  C. L. Silva,et al.  Improve protective efficacy of a TB DNA-HSP65 vaccine by BCG priming , 2007, Genetic vaccines and therapy.

[5]  B. J. Hawgood.  Albert Calmette (1863–1933) and Camille Guérin (1872–1961): the C and G of BCG vaccine , 2007, Journal of medical biography.

[6]  G. Kaplan,et al.  BCG vaccination confers poor protection against M. tuberculosis HN878-induced central nervous system disease. , 2007, Vaccine.

[7]  T. Ottenhoff,et al.  T-Cell Recognition of the HspX Protein of Mycobacterium tuberculosis Correlates with Latent M. tuberculosis Infection but Not with M. bovis BCG Vaccination , 2007, Infection and Immunity.

[8]  K. Uchida,et al.  Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs. , 2007, Tuberculosis.

[9]  I. Orme,et al.  Lymphadenitis as a major element of disease in the guinea pig model of tuberculosis. , 2006, Tuberculosis.

[10]  G. Bjune,et al.  The emergence of Beijing family genotypes of Mycobacterium tuberculosis and low‐level protection by bacille Calmette–Guérin (BCG) vaccines: is there a link? , 2006, Clinical and experimental immunology.

[11]  Sang-Nae Cho,et al.  Enhanced Immunogenicity and Protective Efficacy with the Use of Interleukin-12-Encapsulated Microspheres plus AS01B in Tuberculosis Subunit Vaccination , 2006, Infection and Immunity.

[12]  N. Dhar,et al.  Elicitation of efficient, protective immune responses by using DNA vaccines against tuberculosis. , 2005, Vaccine.

[13]  S. Kaufmann,et al.  Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin. , 2005, The Journal of clinical investigation.

[14]  P. Andersen,et al.  The success and failure of BCG — implications for a novel tuberculosis vaccine , 2005, Nature Reviews Microbiology.

[15]  J. Wain,et al.  Infection Biology of a Novel α-Crystallin of Mycobacterium tuberculosis: Acr21 , 2005, The Journal of Immunology.

[16]  S. Morris,et al.  A polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity. , 2004, Vaccine.

[17]  E. Agger,et al.  The Influence of Remaining Live BCG Organisms in Vaccinated Mice on the Maintenance of Immunity to Tuberculosis , 2004, Scandinavian journal of immunology.

[18]  S. H. Kaufmann,et al.  Comparative proteome analysis of culture supernatant proteins from virulent Mycobacterium tuberculosis H37Rv and attenuated M. bovis BCG Copenhagen , 2003, Electrophoresis.

[19]  S. Ha,et al.  Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis , 2003, Gene Therapy.

[20]  F. Hudecz,et al.  Cytokine profile, HLA restriction and TCR sequence analysis of human CD4+ T clones specific for an immunodominant epitope of Mycobacterium tuberculosis 16‐kDa protein , 2003, Clinical and experimental immunology.

[21]  D. van Soolingen,et al.  A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes , 2003, Clinical and experimental immunology.

[22]  T. Udagawa,et al.  Vaccination of guinea pigs with DNA encoding Ag85A by gene gun bombardment. , 2003, Tuberculosis.

[23]  Yu-Jin Jung,et al.  Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Thomas,et al.  Divergent effect of bacillus Calmette–Guérin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: Implications for primate models in tuberculosis vaccine research , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  P. Andersen,et al.  Protection of Mice with a Tuberculosis Subunit Vaccine Based on a Fusion Protein of Antigen 85B and ESAT-6 , 2001, Infection and Immunity.

[26]  Olivier Denis,et al.  Improved Immunogenicity and Protective Efficacy of a Tuberculosis DNA Vaccine Encoding Ag85 by Protein Boosting , 2001, Infection and Immunity.

[27]  W. Bishai,et al.  Efficacies of BCG and vole bacillus (Mycobacterium microti) vaccines in preventing clinically apparent pulmonary tuberculosis in rabbits: a preliminary report. , 2000, Vaccine.

[28]  B. Barrell,et al.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence , 1998, Nature.

[29]  D. Snider,et al.  The global threat of drug-resistant tuberculosis. , 1998, The New England journal of medicine.

[30]  G. Besra,et al.  Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. , 1997, Science.

[31]  J. Ulmer,et al.  Induction of humoral and cellular immune responses by vaccination with M. tuberculosis antigen 85 DNA. , 1997, Cellular and molecular biology.

[32]  D. Crane,et al.  Stationary phase-associated protein expression in Mycobacterium tuberculosis: function of the mycobacterial alpha-crystallin homolog , 1996, Journal of bacteriology.

[33]  P. E. M. Fine,et al.  Variation in protection by BCG: implications of and for heterologous immunity , 1995, The Lancet.

[34]  D E Snider,et al.  Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. , 1995, JAMA.

[35]  Niang,et al.  T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy , 1994, Infection and immunity.